Evidence map›Paper›PMID 41992360›Full record

ArticleBiological research2026

Characterization of GH18 chitinase in Leishmania braziliensis: expression, structural insights, and implications for vaccine and therapeutic development.

Maura Rojas-Pirela, Marirene Chacón-Arnaude, Cristóbal Lárez-Velásquez, María Verónica Rojas, Constanza Cardenas, Ana J Cáceres, Luis-Antonio Corchete, Diego Andrade-Alviárez, Luis A Prieto-Rojas, Daniel Salete-Granado and 4 more

Abstract read
In one paragraph

Article in Biological research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Maura Rojas-Pirela *Instituto de Investigación Biomédica de Salamanca (IBSAL), 37007, Salamanca, Spain. mrojaspirela@usal.es.ORCID http://orcid.org/0000-0002-4387-2613
Marirene Chacón-Arnaude *Laboratorio de Enzimología de Parásitos, Departamento de Biología, Facultad de Ciencias, Universidad de Los Andes, Mérida, 5101, Venezuela.
Cristóbal Lárez-VelásquezGrupo de Polímeros, Departamento de Química, Universidad de Los Andes, Mérida, Venezuela.ORCID http://orcid.org/0000-0001-8582-4380
María Verónica RojasInstituto de Biología, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, 2373223, Valparaíso, Chile.ORCID http://orcid.org/0000-0003-4410-0380
Constanza CardenasNúcleo de Biotecnología Curauma, Pontificia Universidad Católica de Valparaíso, Av. Universidad 330. 2373223, Valparaíso, Chile.ORCID http://orcid.org/0000-0002-3673-9320
Ana J CáceresLaboratorio de Enzimología de Parásitos, Departamento de Biología, Facultad de Ciencias, Universidad de Los Andes, Mérida, 5101, Venezuela.
Luis-Antonio CorcheteKrantz Family Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA, USA.
Diego Andrade-AlviárezLaboratorio de Enzimología de Parásitos, Departamento de Biología, Facultad de Ciencias, Universidad de Los Andes, Mérida, 5101, Venezuela.ORCID http://orcid.org/0000-0002-8353-9946
Luis A Prieto-RojasFacultad de Medicina, Universidad de Los Andes, Mérida, 5101, Venezuela.
Daniel Salete-GranadoInstituto de Investigación Biomédica de Salamanca (IBSAL), 37007, Salamanca, Spain.ORCID http://orcid.org/0000-0002-3561-3507
María Á Pérez-NietoInstituto de Investigación Biomédica de Salamanca (IBSAL), 37007, Salamanca, Spain.
Wilfredo QuiñonesLaboratorio de Enzimología de Parásitos, Departamento de Biología, Facultad de Ciencias, Universidad de Los Andes, Mérida, 5101, Venezuela.ORCID http://orcid.org/0000-0002-6574-3732
Paul A M MichelsSchool of Biological Sciences, University of Edinburgh, The King's Buildings, Edinburgh, EH9 3FL, UK.ORCID http://orcid.org/0000-0003-3726-6104
Miguel MarcosInstituto de Investigación Biomédica de Salamanca (IBSAL), 37007, Salamanca, Spain.ORCID http://orcid.org/0000-0003-1269-4487

Funding

Agencia Nacional de Investigación y Desarrollo Fondecyt 1240448Instituto de Salud Carlos III CD22/00054Instituto de Salud Carlos III FI21/00189
6 · The paper itself

Abstract

Chitinases, a group of glycosyl hydrolases (GHs), catalyze the degradation of chitin by releasing N-acetylglucosamine subunits. GHs can be found in all three domains of life. Among the three GH families (GH18, GH19, and GH20), GH18 chitinases are the most conserved and extensively studied. These enzymes have been implicated in nutrition, immune modulation, invasion, and virulence across diverse pathogens. In some parasitic protists, GH18 chitinases are essential for transmission. However, in kinetoplastids, including Leishmania spp., these enzymes remain poorly characterized. This study aimed to identify and characterize chitinase across kinetoplastids, with a particular focus on GH18 chitinase in Leishmania braziliensis, the causative agent of muco-cutaneous leishmaniasis. A bioinformatic pipeline was implemented to retrieve and annotate chitinase genes from multiple databases. Catalytic domains and subcellular localization were identified using dedicated computational tools. Phylogenetic relationships were reconstructed in MEGA12 using maximum likelihood and neighbor-joining methods. RNA-seq data were analyzed to evaluate stage-specific expression. Structural models of L. braziliensis GH18 chitinase (Lbr_ChGH18) were created with AlphaFold and subsequently refined. We identified GH18 chitinases genes across Leishmania species and other kinetoplastids, together with GH19 and GH20 chitinase genes. Lbr_ChGH18 was detected across all life-cycle stages, with peak levels in amastigotes. Docking analyses identified closantel, argifin, and argadin as potential inhibitors of Lbr_ChGH18. Epitope prediction revealed conserved B- and T-cell epitopes in GH18 chitinases from Old and New World Leishmania, capable of binding multiple HLA class I and II molecules, highlighting their potential as diagnostic and vaccine candidates. The discovery of GH20 chitinase-like genes in Trypanosoma species offers new insights into the evolution and functional diversification of GHs in kinetoplastids. The high conservation and expression of GH18 chitinases underscore their potential as promising targets for drug and vaccine development against leishmaniasis.

Indexed as

ChitinasesLeishmania braziliensisAmino Acid SequencePhylogenyVaccine DevelopmentChitinasesGH18 chitinaseKinetoplastid evolutionL. braziliensisTherapeutic targets, vaccine candidates

Identifiers

PMID41992360
PMCPMC13231604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.